Support Journalism
HomeBreaking NewsNirmala Sitharaman allots Rs 35,000 crore for COVID-19 vaccine
Breaking News

Nirmala Sitharaman allots Rs 35,000 crore for COVID-19 vaccine

TheNews21 Bureau
By TheNews21 Bureau

Subscribe to TheNews21

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

Stay Ahead with Independent Journalism

Investigations, political analysis and major national and global stories delivered directly to your inbox.

TheNews21 Bureau
TheNews21 Bureau
Previous article
A framework to be put in place to give power consumer option to chose discoms: FM
Next article
Union Budget: Rahul Gandhi demands support to MSMEs, farmers, workers for employment generation

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Must Read

spot_img

Html code here! Replace this with any non empty text and that's it.

Previous article
A framework to be put in place to give power consumer option to chose discoms: FM
Next article
Union Budget: Rahul Gandhi demands support to MSMEs, farmers, workers for employment generation

Must Read

spot_img

TheNews21 is India’s independent digital news and investigative journalism platform founded by senior journalist Vivek Bhavsar. From its Mumbai newsroom, it reports on governance, politics, public policy, business and international affairs, while publishing in-depth investigative stories in the public interest.

Quick Links

Popular Articles

Taiwan Seeks ‘Meaningful Dialogue’ With China

SC stays production warrant issued against comedian Munawar Faruqui in case lodged in UP for allegedly hurting religious sentiments

Facebook removes nearly 200 accounts linked to white supremacy groups

Plus 2 lecturers forum meets Principal Secretary Education over New Education policy and other issues

Maharashtra: Man sets himself ablaze outside Vidhan Bhavan in Mumbai

Maharashtra: 1 killed, 8 injured in clash between two groups in Akola; 26 people detained

Policy & Legal